Abstract:Background: We sought to explore the potential relationship between serum levels of thyroid hormones with those of androgen and metabolic parameters in women with polycystic ovary syndrome (PCOS). Methods: Data from 1059 Chinese women with PCOS and 1015 healthy women was retrospectively collected. This data including fasting glucose and insulin, thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), total triiodothyronine (TT3), total thyroxine (TT4), anti-thyroperoxidase antibody (ANTI-TPO), anti-thyroglobulin (ATG), dehydroepiandrosterone sulfate (DHEAS), total testosterone (TTE), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), prolactin (PRL), progesterone (PGN), triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL). Thyroid-related indicators were compared between PCOS and non-PCOS patients enrolled in this study. Independent variables of PCOS were compared among subgroups in accordance with the classification of TSH, homeostatic model assessment of insulin resistance (HOMA-IR), and TTE levels. To further explore the association between thyroid hormones levels and correlated metabolic parameters in PCOS, multiple regression analyses were conducted. Results: Our study found that PCOS patients had significantly higher serum TSH, FT3, TT3 and TT4 levels than non-PCOS patients. PCOS patients with TSH >= 2.5 mIU/L had significantly higher TG, fasting insulin, HOMA-IR and homeostatic model assessment of beta-cell function (HOMA-B), however, these patients also displayed significantly lower DHEAS, HDL, and quantitative insulin sensitivity check index (QUICKI) when compared to patients with TSH levels <2.5 mIU/L. PCOS patients with HOMA-IR levels >= 2.5 mIU/L demonstrated significantly higher FT3 and TSH, but lower TT3 when compared to women with HOMA-IR levels <2.5 mIU/L. Four groups divided by TTE displayed significant differences in FT3 in PCOS patients. Multiple linear regression analysis showed that TSH was significantly negatively associated with DHEAS and QUICKI. Conclusions: TSH levels are closely correlated to the metabolic and endocrine characteristics of PCOS, especially dyslipidemia and insulin resistance.

The change and significance of thrombin activatable fibrinolysis inhibitor in patients with polycystic ovary syndrome

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Association of Tumor Markers with Total Testosterone in the Serum of Women with Polycystic Ovary Syndrome

Correlation between renin angiotensin system and insulin resistance & testosterone in women with polycystic ovary syndrome

Changes of Platelet Agglutination Function in Patients with Polycystic Ovary Syndrome

Changes and Significances of Serum Visfatin and TNF-α in Patients with Polycystic Ovary Syndrome

Variations in the Profiles of Vascular-Related Factors Among Different Sub-Types of Polycystic Ovarian Syndrome in Northern China

Clinical application of coagulation fibrinolysis index in patient with ovarian hyperstimulation syndrome

The change of plasma visfatin level in women with polycystic ovary syndrome

The Relationship between Thyroid Hormones and Insulin Resistance in Polycystic Ovary Syndrome Women.

[Autophosphorylation of Erythrocyte Insulin Receptors in Patients with Polycystic Ovary Syndrome].

Free Androgen Index and Irisin in Polycystic Ovary Syndrome.

Analysis of IVF-ET outcomes in patients with polycystic ovarian syndrome with different level of Insulin resistance

Elevated Circulating Levels of Irisin and the Effect of Metformin Treatment in Women with Polycystic Ovary Syndrome.

Relationship between hyperandrogen and impaired glucose regulation in women with polycystic ovary syndrome

Clinical study of insulin resistance in women with polycystic ovary syndrome

Change and Significance of Visfatin, C-Reactive Protein and Monocyte Chemoattractant Protein-1 in Polycystic Ovary Syndrome Patients

Endocrine Status of Patients with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation

Association Between Serum Level of Interleukin-18 and Insulin Resistance in Women with Polycystic Ovary Syndrome

Expression of Serum Angiopoietin Like Protein 4 in Patients with Polycystic Ovary Syndrome

Change and Significance of Adiponectin and C-Reactive Protein in Polycystic Ovary Syndrome Patients